Screening of compound libraries against cells is usually limited to characterizing the effects of molecules against a single cell line or drug target. The ability to study the effects of a compound on ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capital has enabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback